May. 20 at 9:15 PM
$SLS $LLY $PFE The share price will continue to Climb until it Launches
- 80th Event PR is coming - it is INEVITABLE.
- and the Registrational Phase 3 Results will give Gps the Fda Green light to Generate Billions in Real Revenue Each Year
- Billions of Dollars that are worth Several Tens of Billions to Big Pharma -
$LLY $PFE
Gps Immunotherapy will set records for patient uptake rates, 3x 4x OS Benefit for 100,000 AML Patients Currently in Remission.
- Pristine Safety Profile
- Easy to administer / manufacture, high margin
- FDA/EU Orphan / Fast Track RPRD +200M CASH
- IP Rights into 2037.
